close
close
migores1

Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Gap Up to $137.46

Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report ) were lower in pre-market trading on Thursday. The stock had previously closed at $137.46 but opened at $145.63. Direxion Daily S&P Biotech Bull 3x Shares last traded at $145.30 with a volume of 409,276 shares.

Direxion Daily S&P Biotech Bull 3x Stock Price Performance

The firm has a fifty day moving average of $132.90 and a 200 day moving average of $120.76.

Institutional Investors Intervene on Direxion Daily S&P Biotech Bull 3x Shares

Large investors have recently made changes to their positions in the company. Headlands Technologies LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at $68,000. Foundations Investment Advisors LLC boosted its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 25.3% in the second quarter. Foundations Investment Advisors LLC now owns 4,087 shares of the company’s stock worth $464,000 after buying an additional 825 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at about $596,000. Traynor Capital Management Inc. raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 73.8% in the second quarter. Traynor Capital Management Inc. now owns 10,089 shares of the company’s stock valued at $1,144,000 after purchasing an additional 4,285 shares during the last quarter. Finally, SG Americas Securities LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 82.8% during the second quarter. SG Americas Securities LLC now owns 2,142 shares of the company’s stock valued at $243,000 after purchasing an additional 970 shares during the last quarter.

About Direxion Daily S&P Biotech Bull 3x Shares

Want more great investment ideas?

(Get a free report)

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry Index. The fund provides three times daily exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

See Also

Get news and ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Direxion Daily S&P Biotech Bull 3x stocks and related companies with MarketBeat ‘s FREE daily email newsletter. com.

Related Articles

Back to top button